Rachael L. Hulshizer

Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma

Michele R. Erickson‐Johnson, Amber R. Seys, Christopher W. Roth et al. · Modern Pathology · 2009 · 62 citations · Full text

Medicine, Oncology, Pathology +13

Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality

Cristiane M. Ida, Kristen A. Rolig, Rachael L. Hulshizer et al. · Cancer Genetics and Cytogenetics · 2007 · 31 citations

Medicine, Oncology, Pathology +9

Array CGH on unstimulated blood does not detect all cases of Pallister–Killian syndrome: A skin biopsy should remain the diagnostic gold standard

Jennelle C. Hodge, Rachael L. Hulshizer, Pam Seger et al. · American Journal of Medical Genetics Part A · 2012 · 22 citations

Life Sciences, Molecular Biology, Molecular Genetics +12

Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900)

Gail H. Vance, Haesook Kim, Gary A. Hicks et al. · Leukemia Research · 2006 · 20 citations

Life Sciences, Genetics, Oncology +15

Identification of novel <i>HMGA2</i> fusion sequences in lipoma: Evidence that deletion of let‐7 miRNA consensus binding site 1 in the <i>HMGA2</i> 3′ UTR is not critical for <i>HMGA2</i> transcriptional upregulation

Xiaoke Wang, Rachael L. Hulshizer, Michele R. Erickson‐Johnson et al. · Genes Chromosomes and Cancer · 2009 · 16 citations

Life Sciences, Genetics, Molecular Genetics +13